Society guideline links: Interstitial lung disease

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately:

●(See "Society guideline links: Lymphangioleiomyomatosis".)

●(See "Society guideline links: Sarcoidosis".)

●(See "Society guideline links: Pneumoconiosis".)

International

●Fleischner Society: White paper on diagnostic criteria for idiopathic pulmonary fibrosis (2018)

●Fleischner Society: Position paper on CT staging and monitoring of fibrotic interstitial lung diseases in clinical practice and treatment trials (2015)

Canada

●Canadian Thoracic Society (CTS): Position statement on long-term monitoring of patients with fibrotic interstitial lung disease (2020)

●CTS: Position statement for comprehensive management of fibrotic interstitial lung diseases (2018)

●CTS: Position statement for evaluation of patients with fibrotic interstitial lung disease (2017)

United States

●American Thoracic Society (ATS): An official clinical practice guideline for treatment of systemic sclerosis-associated interstitial lung disease – Evidence-based recommendations (2023)

●ATS/European Respiratory Society (ERS)/Japanese Respiratory Society (JRS)/Asociación Latinoamericana de Tórax (ALAT): An official clinical practice guideline on idiopathic pulmonary fibrosis and progressive pulmonary fibrosis in adults, update (2022)

●American College of Chest Physicians (CHEST): Guideline and expert panel report on diagnosis and evaluation of hypersensitivity pneumonitis (2021)

●American College of Radiology (ACR): ACR Appropriateness Criteria on diffuse lung disease (2021)

●CHEST: Guideline and expert panel report on transbronchial cryobiopsy for the diagnosis of interstitial lung diseases (2020)

●ATS/JRS/ALAT: An official clinical practice guideline on the diagnosis of hypersensitivity pneumonitis in adults (2020)

●ACR: ACR Appropriateness Criteria on occupational lung diseases (2019)

●CHEST: Guideline and expert panel report for treatment of interstitial lung disease associated cough (2018)

●American College of Occupational and Environmental Medicine (ACOEM): Guidelines on occupational interstitial lung diseases (2015)

●ERS/ATS: Official research statement on interstitial pneumonia with autoimmune features (2015)

●ATS/ERS: Official statement on the international multidisciplinary classification of the idiopathic interstitial pneumonias, update (2013)

●ATS: Official clinical practice guideline on the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease (2012)

Europe

●European Respiratory Society (ERS): Clinical practice guideline on palliative care for people with chronic obstructive pulmonary disease or interstitial lung disease (2023)

●American Thoracic Society (ATS)/ERS/Japanese Respiratory Society (JRS)/Asociación Latinoamericana de Tórax (ALAT): An official clinical practice guideline on idiopathic pulmonary fibrosis and progressive pulmonary fibrosis in adults, update (2022)

●ERS/ATS: Official research statement on interstitial pneumonia with autoimmune features (2015)

●ATS/ERS: Official statement on the international multidisciplinary classification of the idiopathic interstitial pneumonias, update (2013)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Clinical guideline on idiopathic pulmonary fibrosis in adults – Diagnosis and management (2013, updated 2017)

●NICE: Quality standard on idiopathic pulmonary fibrosis in adults (2015)

Australia–New Zealand

●Thoracic Society of Australia and New Zealand (TSANZ): Position statement on the diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand (2020)

●TSANZ and Lung Foundation Australia (LFA): Position statement from the interstitial lung disease multidisciplinary meeting (2017)

●TSANZ and LFA: Position statement for treatment of idiopathic pulmonary fibrosis in Australia and New Zealand (2017)

Japan

●[In Japanese] Japanese Respiratory Society (JRS): Guidelines for the treatment of idiopathic pulmonary fibrosis, revised 2nd edition (2023)

●[In English] American Thoracic Society (ATS)/European Respiratory Society (ERS)/JRS/Asociación Latinoamericana de Tórax (ALAT): An official clinical practice guideline on idiopathic pulmonary fibrosis and progressive pulmonary fibrosis in adults, update (2022)

●[In Japanese] JRS: Guidance for the diagnosis and treatment of idiopathic interstitial pneumonia, revised 4th edition (2022)

●[In Japanese] JRS: Interstitial lung disease associated with collagen disease – Diagnosis and treatment guidelines, 2020 (updated 2021)

●[In English] ATS/JRS/ALAT: An official clinical practice guideline on the diagnosis of hypersensitivity pneumonitis in adults (2020)